Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer
This study has been completed.
Sponsor:
Harold J. Burstein, MD, PhD
Collaborators:
Dana-Farber Cancer Institute
Genentech
Bristol-Myers Squibb
Massachusetts General Hospital
Beth Israel Deaconess Medical Center
Harvard Vanguard Medical Associates
Brigham and Women's Hospital
Information provided by (Responsible Party):
Harold J. Burstein, MD, PhD, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT00136539
First received: August 26, 2005
Last updated: February 15, 2013
Last verified: February 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | March 2012 |
| Primary Completion Date: | November 2006 (Final data collection date for primary outcome measure) |